These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15692061)

  • 41. The marginating-pulmonary immune compartment in mice exhibits increased NK cytotoxicity and unique cellular characteristics.
    Benish M; Melamed R; Rosenne E; Neeman E; Sorski L; Levi B; Shaashua L; Matzner P; Ben-Eliyahu S
    Immunol Res; 2014 Jan; 58(1):28-39. PubMed ID: 24132552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases.
    Borrego F; Peña J; Solana R
    Eur J Immunol; 1993 May; 23(5):1039-43. PubMed ID: 8477800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.
    Jinushi M; Takehara T; Kanto T; Tatsumi T; Groh V; Spies T; Miyagi T; Suzuki T; Sasaki Y; Hayashi N
    J Immunol; 2003 Feb; 170(3):1249-56. PubMed ID: 12538683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of human T cells obtained pre- and post-interleukin-2 (IL-2) therapy by anti-CD3 monoclonal antibody plus IL-2: implications for combined in vivo treatment.
    Weil-Hillman G; Schell K; Segal DM; Hank JA; Sosman JA; Sondel PM
    J Immunother (1991); 1991 Aug; 10(4):267-77. PubMed ID: 1834166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
    Anderson PM; Blazar BR; Bach FH; Ochoa AC
    J Immunol; 1989 Feb; 142(4):1383-94. PubMed ID: 2521662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.
    Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W
    Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control of Metastases via Myeloid CD39 and NK Cell Effector Function.
    Yan J; Li XY; Roman Aguilera A; Xiao C; Jacoberger-Foissac C; Nowlan B; Robson SC; Beers C; Moesta AK; Geetha N; Teng MWL; Smyth MJ
    Cancer Immunol Res; 2020 Mar; 8(3):356-367. PubMed ID: 31992567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β.
    Brownlie D; Doughty-Shenton D; Yh Soong D; Nixon C; O Carragher N; M Carlin L; Kitamura T
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33472858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent.
    Scott MJ; Hoth JJ; Stagner MK; Gardner SA; Peyton JC; Cheadle WG
    Clin Exp Immunol; 2004 Sep; 137(3):469-77. PubMed ID: 15320895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-metastatic activity induced by the in vivo activation of purified protein derivative (PPD)-recognizing Th1 type CD4+ T cells.
    Shinomiya Y; Harada M; Kurosawa S; Okamoto T; Terao H; Matsuzaki G; Shirakusa T; Nomoto K
    Immunobiology; 1995 Aug; 193(5):439-55. PubMed ID: 8522359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
    Cederarv M; Söderberg-Nauclér C; Odeberg J
    Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural analysis of the CD69 early activation antigen by two monoclonal antibodies directed to different epitopes.
    Gerosa F; Tommasi M; Scardoni M; Accolla RS; Pozzan T; Libonati M; Tridente G; Carra G
    Mol Immunol; 1991; 28(1-2):159-68. PubMed ID: 1707136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soypeptide lunasin in cytokine immunotherapy for lymphoma.
    Chang HC; Lewis D; Tung CY; Han L; Henriquez SM; Voiles L; Lupov IP; Pelloso D; Sinn AL; Pollok KE; de Lumen BO; Li F; Blum JS; Srivastava S; Robertson MJ
    Cancer Immunol Immunother; 2014 Mar; 63(3):283-95. PubMed ID: 24363024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.
    Imboden M; Murphy KR; Rakhmilevich AL; Neal ZC; Xiang R; Reisfeld RA; Gillies SD; Sondel PM
    Cancer Res; 2001 Feb; 61(4):1500-7. PubMed ID: 11245457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection.
    Vega-Ramos J; Alari-Pahissa E; Valle JD; Carrasco-Marín E; Esplugues E; Borràs M; Martínez-A C; Lauzurica P
    Immunol Cell Biol; 2010 Oct; 88(7):707-15. PubMed ID: 20440294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma.
    Konjević G; Jović V; Vuletić A; Radulović S; Jelić S; Spuzić I
    Eur J Clin Invest; 2007 Nov; 37(11):887-96. PubMed ID: 17973783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.
    El-Sherbiny YM; Holmes TD; Wetherill LF; Black EV; Wilson EB; Phillips SL; Scott GB; Adair RA; Dave R; Scott KJ; Morgan RS; Coffey M; Toogood GJ; Melcher AA; Cook GP
    Clin Exp Immunol; 2015 Apr; 180(1):98-107. PubMed ID: 25469725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells.
    Mita Y; Kimura MY; Hayashizaki K; Koyama-Nasu R; Ito T; Motohashi S; Okamoto Y; Nakayama T
    Int Immunol; 2018 Nov; 30(12):559-567. PubMed ID: 30085193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.